Spots Global Cancer Trial Database for Immunoscore as Decision Guidance for Adjuvant Chemotherapy in Colon Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Immunoscore as Decision Guidance for Adjuvant Chemotherapy in Colon Cancer
Official Title: iMmunoscore Associated Decision GuIdance for adjuvaNt Chemotherapy and Physical Exercise in Stage III Colon Cancer (iMAGINE): a Prospective, Randomized, Open-label, Multicenter, Phase III Clinical Trial
Study ID: NCT04488159
Conditions
Study Description
Brief Summary: The overall aim of this study is to prospectively validate the superiority of the Immunoscore as a decision guidance for adjuvant chemotherapy in stage III colon cancer patients, in comparison to the conventional TNM-based high- or low-risk classification.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Medical University of Vienna, Vienna, , Austria
Contact Details
Name: Jérôme Galon, PhD
Affiliation: Laboratory of Integrative Cancer Immunology, INSERM, Cordeliers Research Center
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
